A
Arecor Therapeutics PLC
LSE:AREC
Arecor Therapeutics PLC
LSE:AREC
Price:
68.5
GBX
3.01%
Market Closed
Market Cap:
£25.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Arecor Therapeutics PLC
LSE:AREC
|
UK |
|
A
|
Agora SA
WSE:AGO
|
PL |
|
Elgi Equipments Ltd
NSE:ELGIEQUIP
|
IN |
|
A
|
Adeka Corp
TSE:4401
|
JP |
|
K I C Metaliks Ltd
BSE:513693
|
IN |
|
Emami Ltd
NSE:EMAMILTD
|
IN |
|
Salvatore Ferragamo SpA
MIL:SFER
|
IT |
|
G
|
Global Electrical Technology Corp
VN:GLT
|
VN |
|
Brookfield Renewable Corp
NYSE:BEPC
|
US |
|
I
|
Imperium Financial Group Ltd
HKEX:8029
|
HK |
Income Statement
Earnings Waterfall
Arecor Therapeutics PLC
Arecor Therapeutics PLC
Income Statement
Arecor Therapeutics PLC
Arecor Therapeutics PLC
Currency: GBP
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
1
+20%
|
2
+73%
|
3
+41%
|
5
+35%
|
5
+7%
|
5
+3%
|
5
+0%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(5)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
(0)
N/A
|
|
| Operating Income | |||||||||
| Operating Expenses |
(7)
|
(10)
|
(13)
|
(14)
|
(14)
|
(14)
|
(9)
|
(5)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(5)
|
(8)
|
(8)
|
(9)
|
(6)
|
(4)
|
|
| Research & Development |
(5)
|
(8)
|
(9)
|
(7)
|
(6)
|
(5)
|
(3)
|
(2)
|
|
| Depreciation & Amortization |
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Operating Income |
(6)
N/A
|
(9)
-46%
|
(10)
-20%
|
(10)
+1%
|
(9)
+12%
|
(9)
0%
|
(7)
+20%
|
(6)
+23%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
(1)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Non-Reccuring Items |
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(3)
|
(3)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(7)
N/A
|
(9)
-26%
|
(11)
-21%
|
(10)
+5%
|
(9)
+12%
|
(9)
+0%
|
(11)
-19%
|
(8)
+21%
|
|
| Net Income | |||||||||
| Tax Provision |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(6)
|
(7)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(8)
|
|
| Net Income (Common) |
(6)
N/A
|
(7)
-20%
|
(9)
-25%
|
(9)
-2%
|
(9)
+9%
|
(9)
-1%
|
(10)
-18%
|
(8)
+21%
|
|
| EPS (Diluted) |
-0.27
N/A
|
-0.26
+4%
|
-0.32
-23%
|
-0.31
+3%
|
-0.28
+10%
|
-0.28
N/A
|
-0.31
-11%
|
-0.22
+29%
|
|
Switch to:
Switch to:
See Also
Discover More
